14 Nov 2019 VBI Vaccines and Brii Biosciences Initiate Phase 1b/2a Study of BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B Infection
12 Nov 2019 NEC and VAXIMM Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines
12 Nov 2019 Merck’s ERVEBO® [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union
11 Nov 2019 OSE Immunotherapeutics Presented Positive Correlation Between Neoepitope Response and Increased Survival for NSCLC Patients Treated with Tedopi®
09 Nov 2019 Neon Therapeutics Announces Updated Data Presented at Society for Immunotherapy of Cancer (SITC) Annual Meeting
08 Nov 2019 Boston Biomedical, Inc. Highlights Phase 1 Data Evaluating Investigational WT1 Cancer Peptide Vaccine DSP-7888 (ombipepimut-S*) in Patients with Advanced Malignancies at SITC 2019
08 Nov 2019 Immutep presents positive interim data from phase II TACTI-002 trial at SITC
08 Nov 2019 Johnson & Johnson Announces Submission of European Marketing Authorisation Applications for Janssen’s Investigational Ebola Vaccine Regimen
07 Nov 2019 Takeda’s Dengue Vaccine Candidate Demonstrates Protection in Children Ages Four to 16 Years, Regardless of Previous Dengue Exposure
06 Nov 2019 Heat Biologics Reports Positive Phase 2 Interim Data in NSCLC Patients Who Previously Failed Checkpoint Inhibitor Treatment
06 Nov 2019 Inovio demonstrates 80% 6-month progression-free survival in Phase 2 glioblastoma multiforme (GBM) study
06 Nov 2019 Gritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE Platform and Contained Within its SLATE Immunotherapy
06 Nov 2019 Genocea Presents Preclinical Research that Shows Inhibitory Neoantigens Stifle Protective Anti-Tumor Immune Responses at Society for Immunotherapy of Cancer (SITC)
05 Nov 2019 FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older
30 Oct 2019 Unique Alzheimer's Disease Tau Vaccine Shows Great Potential in Pre-Clinical Studies
29 Oct 2019 Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine
29 Oct 2019 GSK candidate vaccine demonstrates sustained level of protection against active pulmonary tuberculosis
29 Oct 2019 RhoVac Receives Approval in Finland to Start Clinical Phase IIb Study in Prostate Cancer
23 Oct 2019 BlueWillow Receives FDA Clearance to Begin Phase 1 Study of its Intranasal Anthrax Vaccine
18 Oct 2019 Bavarian Nordic Updates on Phase 2 Study of CV301 in Bladder Cancer
18 Oct 2019 Merck Receives EU CHMP Positive Opinion for Investigational V920 Ebola Zaire Vaccine for Protection Against Ebola Virus Disease
17 Oct 2019 Stallergenes Greer and Anergis Initiate New Study to Predict Efficacy of Second-Generation Allergen Immunotherapy
15 Oct 2019 Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults
08 Oct 2019 Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
08 Oct 2019 Prokarium Secures £4.6M from Wellcome to Fund the Clinical Development of its Lead Vaccine Programme

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up